46 related articles for article (PubMed ID: 33959834)
1. Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patients.
Liu MF; Jin C; Wu T; Chen EH; Lu M; Qin HL
Immunol Res; 2021 Jun; 69(3):275-284. PubMed ID: 33959834
[TBL] [Abstract][Full Text] [Related]
2. The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.
Golding A; Hasni S; Illei G; Shevach EM
Arthritis Rheum; 2013 Nov; 65(11):2898-906. PubMed ID: 23925905
[TBL] [Abstract][Full Text] [Related]
3. Human CD4
Brown ME; Peters LD; Hanbali SR; Arnoletti JM; Sachs LK; Nguyen KQ; Carpenter EB; Seay HR; Fuhrman CA; Posgai AL; Shapiro MR; Brusko TM
Front Immunol; 2022; 13():873560. PubMed ID: 35693814
[TBL] [Abstract][Full Text] [Related]
4. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
Elkord E; Abd Al Samid M; Chaudhary B
Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
[TBL] [Abstract][Full Text] [Related]
5. Helios enhances the preferential differentiation of human fetal CD4
Ng MSF; Roth TL; Mendoza VF; Marson A; Burt TD
Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31757834
[TBL] [Abstract][Full Text] [Related]
6. Human small intestine contains 2 functionally distinct regulatory T-cell subsets.
Chauhan SK; Bartolomé Casado R; Landsverk OJB; Johannessen H; Phung D; Nilsen HR; Sætre F; Jahnsen J; Horneland R; Yaqub S; Aandahl EM; Lundin KEA; Bækkevold ES; Jahnsen FL
J Allergy Clin Immunol; 2023 Jul; 152(1):278-289.e6. PubMed ID: 36893861
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells.
Seng A; Krausz KL; Pei D; Koestler DC; Fischer RT; Yankee TM; Markiewicz MA
Blood Adv; 2020 Apr; 4(7):1325-1339. PubMed ID: 32259202
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease.
Morina L; Jones ME; Oguz C; Kaplan MJ; Gangaplara A; Fitzhugh CD; Kanakry CG; Shevach EM; Buszko M
Front Immunol; 2023; 14():1114780. PubMed ID: 37350974
[TBL] [Abstract][Full Text] [Related]
9. Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function.
Thomas RM; Pahl MC; Wang L; Grant SFA; Hancock WW; Wells AD
Elife; 2024 Apr; 12():. PubMed ID: 38655862
[TBL] [Abstract][Full Text] [Related]
10. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3
Wang X; Lang M; Zhao T; Feng X; Zheng C; Huang C; Hao J; Dong J; Luo L; Li X; Lan C; Yu W; Yu M; Yang S; Ren H
Oncogene; 2017 May; 36(21):3048-3058. PubMed ID: 27991933
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD4
Atwany NZ; Hashemi SK; Jayakumar MN; Nagarkatti M; Nagarkatti P; Hassuneh MR
Biology (Basel); 2020 Aug; 9(8):. PubMed ID: 32781652
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity of host Helios
Lupsa N; Érsek B; Böröczky C; Kis D; Szarka E; Lumniczky K; Sáfrány G; Zádori ZS; Szöőr Á; Buzás EI; Pós Z
Eur J Immunol; 2024 Jun; 54(6):e2350619. PubMed ID: 38532599
[TBL] [Abstract][Full Text] [Related]
13. Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients.
Zhdanov DD; Gladilina YA; Blinova VG; Abramova AA; Shishparenok AN; Eliseeva DD
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790984
[TBL] [Abstract][Full Text] [Related]
14. Treg in inborn errors of immunity: gaps, knowns and future perspectives.
Kennedy-Batalla R; Acevedo D; Luo Y; Esteve-Solé A; Vlagea A; Correa-Rocha R; Seoane-Reula ME; Alsina L
Front Immunol; 2023; 14():1278759. PubMed ID: 38259469
[TBL] [Abstract][Full Text] [Related]
15. Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures.
Katzke VA; Le Cornet C; Mahfouz R; Brauer B; Johnson T; Canzian F; Rebours V; Boutron-Ruault MC; Severi G; Schulze MB; Olsen A; Tjønneland A; Overvad K; Crous-Bou M; Molina-Montes E; Amiano P; Huerta JM; Ardanaz E; Perez-Cornago A; Masala G; Pala V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Vermeulen R; Sund M; Franklin O; Christakoudi S; Dossus L; Weiderpass E; Olek S; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2179-2187. PubMed ID: 34548327
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of exTreg induction.
Saxena V; Lakhan R; Iyyathurai J; Bromberg JS
Eur J Immunol; 2021 Aug; 51(8):1956-1967. PubMed ID: 33975379
[TBL] [Abstract][Full Text] [Related]
17. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.
Sato K; Yamashita-Kanemaru Y; Abe F; Murata R; Nakamura-Shinya Y; Kanemaru K; Muratani M; Veillette A; Goto M; Ito M; Shibuya A; Shibuya K
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011606
[TBL] [Abstract][Full Text] [Related]
18. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation.
Mijnheer G; Lutter L; Mokry M; van der Wal M; Scholman R; Fleskens V; Pandit A; Tao W; Wekking M; Vervoort S; Roberts C; Petrelli A; Peeters JGC; Knijff M; de Roock S; Vastert S; Taams LS; van Loosdregt J; van Wijk F
Nat Commun; 2021 May; 12(1):2710. PubMed ID: 33976194
[TBL] [Abstract][Full Text] [Related]
19. c-Rel employs multiple mechanisms to promote the thymic development and peripheral function of regulatory T cells in mice.
Fulford TS; Grumont R; Wirasinha RC; Ellis D; Barugahare A; Turner SJ; Naeem H; Powell D; Lyons PA; Smith KGC; Scheer S; Zaph C; Klein U; Daley SR; Gerondakis S
Eur J Immunol; 2021 Aug; 51(8):2006-2026. PubMed ID: 33960413
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
